- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05950438
Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
May 21, 2026 updated by: Ankit Bharat, Northwestern University
A Prospective Clinical Registry Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure.
Clinical (or health) outcomes measure the effect of the procedure on your overall health status.
During this procedure, the surgeon will remove all or part of your esophagus.
We want to identify patients who will have this procedure.
We will look at data elements before, during, and after your procedure to understand the impact of this surgery on your post-operative clinical outcomes.
Study Overview
Detailed Description
Esophagectomy is a complex surgical procedure performed to treat various esophageal disorders.
The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract.
Different surgical approaches and techniques have been developed, including open (transthoracic or transhiatal), minimally invasive (video-assisted thoracoscopic surgery or robotic-assisted), and hybrid approaches.
These techniques may yield different clinical outcomes, and there is still ongoing debate regarding the optimal approach.
Nevertheless, minimally invasive approaches, including robotic esophagectomy, are generally preferred given the lower morbidity.
This prospective clinical registry aims to investigate outcomes of elective robotic transhiatal esophagectomy, the preferred approach at Northwestern Memorial Hospital, for adult patients undergoing this procedure.
By collecting clinical and demographic data prospectively, we hope to identify factors that contribute to improved outcomes and guide future surgical practice.
Study Type
Observational
Enrollment (Estimated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ankit Bharat, MD
- Phone Number: 312-926-7628
- Email: ankit.bharat@northwestern.edu
Study Contact Backup
- Name: Sara Krezalek, BSN
- Phone Number: 312-926-7577
- Email: sara.krezalek@nm.org
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Recruiting
- Northwestern University
-
Contact:
- Sara Krezalek, BSN
- Phone Number: 3129267577
- Email: sara.krezalek@nm.org
-
Contact:
- Ankit Bharat, MD
- Phone Number: 3129267628
- Email: ankit.bharat@northwestern.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Participants will be identified in the Thoracic Surgery clinic or in the inpatient setting based on the surgeon's expertise who need to undergo an elective esophagectomy procedure.
Description
Inclusion Criteria:
- Adult patients (18 years or older)
- Patients undergoing elective esophagectomy for any indication
- Patients who have already had an elective esophagectomy for any indication
- Patients with consent providing capacity
Exclusion Criteria:
- Patients undergoing emergent esophagectomy
- Adults unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Pregnant women
- Prisoners
- Vulnerable Populations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants with Anastomotic Leak
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Esophageal Stricture
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Pneumonia
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants Requiring Ventilation >48 Hours
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Empyema
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Pulmonary Embolism
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Deep Venous Thrombosis
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Gastric Outlet Obstruction
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Stroke
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Atrial Fibrillation
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Vocal Cord Paralysis
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Myocardial Infarction
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Chylothorax
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Acute Renal Injury
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Wound Infections
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Rates of Re-operation
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Rates of Re-Admission
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Number of Participants with Intensive Care Unit (ICU) Stay
Time Frame: During first 3 months postop
|
Postoperative Complication
|
During first 3 months postop
|
|
Rates of Length of Hospital Stay
Time Frame: Postoperative
|
Postoperative Complication
|
Postoperative
|
|
Rates of 30-day Survival
Time Frame: Postoperative
|
Postoperative Complication
|
Postoperative
|
|
Rates of 90-day Survival Rates
Time Frame: Postoperative
|
Postoperative Complication
|
Postoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Operative Time of Surgery
Time Frame: Intraoperative
|
Length of Surgery
|
Intraoperative
|
|
Rates of Blood Loss
Time Frame: Intraoperative
|
Did the Participant Lose Any Blood During the Surgery
|
Intraoperative
|
|
Number of Participants with Conversion Rates to Open Esophagectomy
Time Frame: Intraoperative
|
Intraoperative
|
|
|
Number of Participants with Lymph nodes in the Final Specimen
Time Frame: Intraoperative
|
Pathological Variables
|
Intraoperative
|
|
Number of Participants with Proximal and Distal Margins
Time Frame: Intraoperative
|
Pathological Variables
|
Intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ankit Bharat, MD, Northwestern University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 11, 2023
Primary Completion (Estimated)
May 25, 2028
Study Completion (Estimated)
May 25, 2028
Study Registration Dates
First Submitted
July 11, 2023
First Submitted That Met QC Criteria
July 11, 2023
First Posted (Actual)
July 18, 2023
Study Record Updates
Last Update Posted (Actual)
May 26, 2026
Last Update Submitted That Met QC Criteria
May 21, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00219267
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Esophagectomy
-
University of PittsburghActive, not recruitingEsophagectomyUnited States
-
Shizuoka Cancer CenterCompleted
-
University of CologneDepartment of General, Visceral, Tumor and Transplant Surgery, University... and other collaboratorsCompletedTransthoracic EsophagectomyGermany
-
University of Wisconsin, MadisonCompletedPancreaticoduodenectomy | EsophagectomyUnited States
-
Yonsei UniversityRecruitingEndotracheal Intubation | Esophagectomy | Robotic EsophagectomyKorea, Republic of
-
University of VirginiaUnknownTransthoracic EsophagectomyUnited States
-
Erasme University HospitalNot yet recruitingHemodynamic Instability | Esophagectomy | Epidural; Anesthesia | Paravertebral Anesthesia
-
Region SkaneCompletedEsophagectomy | Esophageal and/or Cardia Cancer | Gastric Pull-up ReconstructionSweden
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Kaplan Medical CenterUnknownPostoperative Complications | Esophagectomy
Clinical Trials on Esophagectomy
-
GEM Hospital & Research CenterUnknown
-
Austrian Society Of Surgical OncologyCompletedEsophageal Cancer
-
University of California, IrvineWithdrawn
-
Sichuan UniversityUnknownPostoperative Complications | Esophageal Cancer | Pulmonary Function | DiaphragmChina
-
Shanghai Chest HospitalChanghai Hospital; The First Affiliated Hospital of Nanchang University; Shanghai... and other collaboratorsRecruitingEsophageal Cancer | Esophageal CarcinomaChina
-
University Hospital, LilleNot yet recruitingResecable Esophageal or Gastroesophageal Junction CancerFrance
-
Cancer Institute and Hospital, Chinese Academy...Zhejiang Cancer Hospital; Sun Yat-sen University; Shanghai Zhongshan Hospital; Fujian... and other collaboratorsUnknown
-
University of BolognaCompletedAdenocarcinoma of the Esophagus | Adenocarcinoma of the Gastric CardiaItaly
-
Fudan UniversityCompleted
-
Shanghai Zhongshan HospitalCompletedLymph Node MetastasisChina